User page of Jordan Smith!

User´s activity

Last login 1 day(s) ago
Registered 69 day(s) ago

Shortcuts

Links · Articles · Businesses

Profile images

Targeted Protein Degradation and the Rise of Kymera Therapeutics | Blog Pharmaceuticals

Targeted Protein Degradation and the Rise of Kymera Therapeutics | Blog Pharmaceuticals

Submitted 6 day(s) ago

Nurix betters Kymera: The Targeted Protein Degradation War Is Heating Up % | Blog

Nurix betters Kymera: The Targeted Protein Degradation War Is Heating Up % | Blog

Submitted 6 day(s) ago

Cell Therapy Manufacturing: Here are the Key Innovations | Blog Gene Therapy

Cell Therapy Manufacturing: Here are the Key Innovations | Blog Gene Therapy

Submitted 6 day(s) ago

Immuno-Oncology Biomarker: Benchmarking Big Pharma Activity | Blog Diagnostics

Immuno-Oncology Biomarker: Benchmarking Big Pharma Activity | Blog Diagnostics

Submitted 6 day(s) ago

Contraband in the Clinical Trials -A saga of the great apes | Blog

Contraband in the Clinical Trials -A saga of the great apes | Blog

Submitted 6 day(s) ago

COVID-19 Impact on Gene Therapy Market | Blog Gene Therapy

COVID-19 Impact on Gene Therapy Market | Blog Gene Therapy

Submitted 7 day(s) ago

Continuous Manufacturing: Solution to Pharmaceutical Manufacturing Industry's COVID-19 Concerns | Blog Pharmaceuticals

Continuous Manufacturing: Solution to Pharmaceutical Manufacturing Industry's COVID-19 Concerns | Blog Pharmaceuticals

Submitted 7 day(s) ago

COVID-19 Impact on Cell and Gene Therapy Manufacturing Market | Blog Cell Therapy

COVID-19 Impact on Cell and Gene Therapy Manufacturing Market | Blog Cell Therapy

Submitted 7 day(s) ago

NHS Advises COVID-19 Related Risk Assessment of Phase I Trials | Blog Clinical Trials

NHS Advises COVID-19 Related Risk Assessment of Phase I Trials | Blog Clinical Trials

Submitted 7 day(s) ago

Coronavirus: Stem Cell Contract Manufacturing Demand to Surge | Blog

Coronavirus: Stem Cell Contract Manufacturing Demand to Surge | Blog

Submitted 7 day(s) ago

Fragment-based Drug Discovery – A Boon in Disguise to get a | Blog

Fragment-based Drug Discovery – A Boon in Disguise to get a | Blog

Submitted 7 day(s) ago

Targeted Protein Degradation and the Rise of Kymera Therapeutics | Blog Pharmaceuticals

Targeted Protein Degradation and the Rise of Kymera Therapeutics | Blog Pharmaceuticals

Submitted 7 day(s) ago

Nurix betters Kymera: The Targeted Protein Degradation War Is Heating Up % | Blog

Nurix betters Kymera: The Targeted Protein Degradation War Is Heating Up % | Blog

Submitted 7 day(s) ago

Cell Therapy Manufacturing: Here are the Key Innovations | Blog Gene Therapy

Cell Therapy Manufacturing: Here are the Key Innovations | Blog Gene Therapy

Submitted 7 day(s) ago

Autolus Therapeutics Presents Preclinical Data on AUT06NG | Blog

Autolus Therapeutics Presents Preclinical Data on AUT06NG | Blog

Submitted 12 day(s) ago

Rise of Novel Non-Invasive Methods | Roots Analysis Blog

Rise of Novel Non-Invasive Methods | Roots Analysis Blog

Submitted 12 day(s) ago

Rise of Novel Non-Invasive Methods | Roots Analysis Blog

Rise of Novel Non-Invasive Methods | Roots Analysis Blog

Submitted 12 day(s) ago

DNA Encoded Libraries: Big Pharma Interest Rises as Technol | Blog

DNA Encoded Libraries: Big Pharma Interest Rises as Technol | Blog

Submitted 12 day(s) ago

Targeted Protein Degradation Market: Riding on the... | Roots Analysis Blog

Targeted Protein Degradation Market: Riding on the... | Roots Analysis Blog

Submitted 12 day(s) ago

Growth Drivers and Roadblocks in Targeted Protein Degradation | Blog

Growth Drivers and Roadblocks in Targeted Protein Degradation | Blog

Submitted 12 day(s) ago

A Pizza Hut Prescription for Gene Therapy Companies | Blog Gene Therapy

A Pizza Hut Prescription for Gene Therapy Companies | Blog Gene Therapy

Submitted 13 day(s) ago

CMO, CMO Everywhere, Not a Single One That Fits

CMO, CMO Everywhere, Not a Single One That Fits

Submitted 13 day(s) ago

Cell Line Engineering is the Most Common Service Offered | Blog

Cell Line Engineering is the Most Common Service Offered | Blog

Submitted 13 day(s) ago

Cell Line Engineering is the Most Common Service Offered | Blog

Cell Line Engineering is the Most Common Service Offered | Blog

Submitted 13 day(s) ago

61% of the Genome Editing Service Providers | Roots Analysis Blog

61% of the Genome Editing Service Providers | Roots Analysis Blog

Submitted 13 day(s) ago

Autolus Therapeutics Presents Preclinical Data on AUT06NG | Blog

Autolus Therapeutics Presents Preclinical Data on AUT06NG | Blog

Submitted 14 day(s) ago

Rise of Novel Non-Invasive Methods | Roots Analysis Blog

Rise of Novel Non-Invasive Methods | Roots Analysis Blog

Submitted 14 day(s) ago

DNA Encoded Libraries: Big Pharma Interest Rises as Technol | Blog

DNA Encoded Libraries: Big Pharma Interest Rises as Technol | Blog

Submitted 14 day(s) ago

Targeted Protein Degradation Market: Riding on the... | Roots Analysis Blog

Targeted Protein Degradation Market: Riding on the... | Roots Analysis Blog

Submitted 14 day(s) ago

Growth Drivers and Roadblocks in Targeted Protein Degradation | Blog

Growth Drivers and Roadblocks in Targeted Protein Degradation | Blog

Submitted 14 day(s) ago

CARsgen anti-BCMA CAR T Therapy Receives RMAT Designation | Blog

CARsgen anti-BCMA CAR T Therapy Receives RMAT Designation | Blog

Submitted 19 day(s) ago

Avantgen Enters a Strategic Collaboration Agreement for its | Blog

Avantgen Enters a Strategic Collaboration Agreement for its | Blog

Submitted 19 day(s) ago

T-Cell Therapies Funding Update: Tmunity Raises $75 Million.. | Blog

T-Cell Therapies Funding Update: Tmunity Raises $75 Million.. | Blog

Submitted 19 day(s) ago

Party Like Celebrities: American Gene Technologies Hosts a Red...

Party Like Celebrities: American Gene Technologies Hosts a Red...

Submitted 19 day(s) ago

CRISPR-edited Immune Cells Prove Safe in Small Cancer Study | Blog Genomics

CRISPR-edited Immune Cells Prove Safe in Small Cancer Study | Blog Genomics

Submitted 19 day(s) ago

ADCs Pipeline Update: Daiichi Sankyo Initiates Clinical Trial | Blog

ADCs Pipeline Update: Daiichi Sankyo Initiates Clinical Trial | Blog

Submitted 20 day(s) ago

The Treasure Hunt for Novel Biomarkers and Rise of TMB | Blog

The Treasure Hunt for Novel Biomarkers and Rise of TMB | Blog

Submitted 20 day(s) ago

ADCs Pipeline Update: Sutro Biopharma Presents | Roots Analysis Blog

ADCs Pipeline Update: Sutro Biopharma Presents | Roots Analysis Blog

Submitted 20 day(s) ago

ADCs Pipeline Update: Femtogenix Presents Novel Data | Blog

ADCs Pipeline Update: Femtogenix Presents Novel Data | Blog

Submitted 20 day(s) ago

Antibody Drug Conjugates Market Update: Ambrx and NovoCodex | Blog

Antibody Drug Conjugates Market Update: Ambrx and NovoCodex | Blog

Submitted 20 day(s) ago

ADCs Pipeline Update: Avacta Partners with ADC Therapeutics | Blog

ADCs Pipeline Update: Avacta Partners with ADC Therapeutics | Blog

Submitted 21 day(s) ago

Stem Cell Therapy Contract Manufacturing Market | Blog Stem Cell Therapy

Stem Cell Therapy Contract Manufacturing Market | Blog Stem Cell Therapy

Submitted 21 day(s) ago

Antibody Drug Conjugates Pipeline | Blog Antibody Drug

Antibody Drug Conjugates Pipeline | Blog Antibody Drug

Submitted 21 day(s) ago

Auristatin has Emerged as Most Popular Payload in ADC Clinical Pipeline | Blog Clinical Pipeline

Auristatin has Emerged as Most Popular Payload in ADC Clinical Pipeline | Blog Clinical Pipeline

Submitted 21 day(s) ago

More than 50 Large Volume Wearable Injectors are Available.. | Blog

More than 50 Large Volume Wearable Injectors are Available.. | Blog

Submitted 21 day(s) ago

Alzheimer's Pipeline Update: Biogen Takes a U-Turn on Failed.. | Blog

Alzheimer's Pipeline Update: Biogen Takes a U-Turn on Failed.. | Blog

Submitted 22 day(s) ago

Cell and Gene Therapy Technology Update: ReNeuron.. | Blog

Cell and Gene Therapy Technology Update: ReNeuron.. | Blog

Submitted 22 day(s) ago

Gene Therapy Funding Update: With a Promise of $100 Million.. | Blog

Gene Therapy Funding Update: With a Promise of $100 Million.. | Blog

Submitted 22 day(s) ago

Cell Line Engineering is the Most Common Service Offered | Blog

Cell Line Engineering is the Most Common Service Offered | Blog

Submitted 41 day(s) ago

61% of the Genome Editing Service Providers | Roots Analysis Blog

61% of the Genome Editing Service Providers | Roots Analysis Blog

Submitted 41 day(s) ago

CARsgen anti-BCMA CAR T Therapy Receives RMAT Designation | Blog

CARsgen anti-BCMA CAR T Therapy Receives RMAT Designation | Blog

Submitted 41 day(s) ago

Avantgen Enters a Strategic Collaboration Agreement for its | Blog

Avantgen Enters a Strategic Collaboration Agreement for its | Blog

Submitted 41 day(s) ago

T-Cell Therapies Funding Update: Tmunity Raises $75 Million.. | Blog

T-Cell Therapies Funding Update: Tmunity Raises $75 Million.. | Blog

Submitted 41 day(s) ago

Party Like Celebrities: American Gene Technologies Hosts a Red...

Party Like Celebrities: American Gene Technologies Hosts a Red...

Submitted 41 day(s) ago

Next Generation Batteries: Mapping the Future Potential | Blog

Next Generation Batteries: Mapping the Future Potential | Blog

Submitted 43 day(s) ago

Bioavailability Enhancement: Current Market Landscape and Future | Blog

Bioavailability Enhancement: Current Market Landscape and Future | Blog

Submitted 43 day(s) ago

New Frontiers in Cancer Therapies: Focus on Transcription Factors | Blog

New Frontiers in Cancer Therapies: Focus on Transcription Factors | Blog

Submitted 43 day(s) ago

Autoinjectors: Technological Evolution, Current Opportunities | Blog

Autoinjectors: Technological Evolution, Current Opportunities | Blog

Submitted 43 day(s) ago

Subcutaneous Biologics, Technologies and Drug Delivery Systems | Blog

Subcutaneous Biologics, Technologies and Drug Delivery Systems | Blog

Submitted 43 day(s) ago

Computer Aided Drug Discovery: Opportunities to Optimize | Blog

Computer Aided Drug Discovery: Opportunities to Optimize | Blog

Submitted 43 day(s) ago

The Meteoric Rise of Digital Therapeutic, Monitoring and Diagnostic | Blog

The Meteoric Rise of Digital Therapeutic, Monitoring and Diagnostic | Blog

Submitted 43 day(s) ago

Cell Therapy Manufacturing: The USD 8 Billion+ Growth Opportunity | Blog

Cell Therapy Manufacturing: The USD 8 Billion+ Growth Opportunity | Blog

Submitted 43 day(s) ago

CAR-T: The Future Roadmap of The USD 15 Billion+ Opportunity | Blog

CAR-T: The Future Roadmap of The USD 15 Billion+ Opportunity | Blog

Submitted 43 day(s) ago

T-Cell Immunotherapy: The Next Big Thing in Immunotherapeutics | Blog

T-Cell Immunotherapy: The Next Big Thing in Immunotherapeutics | Blog

Submitted 48 day(s) ago

Superbugs: The Growing Concern Related to Antibiotic Resistance | Blog

Superbugs: The Growing Concern Related to Antibiotic Resistance | Blog

Submitted 48 day(s) ago

Anti-Counterfeiting Technologies in Healthcare | Roots Analysis Blog

Anti-Counterfeiting Technologies in Healthcare | Roots Analysis Blog

Submitted 48 day(s) ago

Cancer Stem Cells: A Step Closer to the Cure | Blog

Cancer Stem Cells: A Step Closer to the Cure | Blog

Submitted 48 day(s) ago

Trends in Human Health Management: A Journey through Time | Blog

Trends in Human Health Management: A Journey through Time | Blog

Submitted 48 day(s) ago

Genome Editing: Future Potential and Ethical Concerns | Blog

Genome Editing: Future Potential and Ethical Concerns | Blog

Submitted 48 day(s) ago

Social Media in Pharmaceutical Marketing | Roots Analysis

Social Media in Pharmaceutical Marketing | Roots Analysis

Submitted 48 day(s) ago

Generic Drugs: Rising Opportunity for Indian Pharmaceutical Players | Blog Pharmaceuticals

Generic Drugs: Rising Opportunity for Indian Pharmaceutical Players | Blog Pharmaceuticals

Submitted 48 day(s) ago

Genome Editing Services Market Snapshot | Blog Genomics

Genome Editing Services Market Snapshot | Blog Genomics

Submitted 49 day(s) ago

Medical Device Contract Manufacturing Market Size | Blog Medical Device

Medical Device Contract Manufacturing Market Size | Blog Medical Device

Submitted 49 day(s) ago

Experts Highlight Unmet Needs in T-Cell Therapies Market | Blog

Experts Highlight Unmet Needs in T-Cell Therapies Market | Blog

Submitted 49 day(s) ago

More than 50 Large Volume Wearable Injectors are Available.. | Blog

More than 50 Large Volume Wearable Injectors are Available.. | Blog

Submitted 49 day(s) ago

Auristatin has Emerged as Most Popular Payload in ADC Clinical Pipeline | Blog Clinical Pipeline

Auristatin has Emerged as Most Popular Payload in ADC Clinical Pipeline | Blog Clinical Pipeline

Submitted 49 day(s) ago

Antibody Drug Conjugates Pipeline | Blog Antibody Drug

Antibody Drug Conjugates Pipeline | Blog Antibody Drug

Submitted 49 day(s) ago

Cell Therapy Pipeline Update: Talaris Therapeutics Announces.. | Blog

Cell Therapy Pipeline Update: Talaris Therapeutics Announces.. | Blog

Submitted 50 day(s) ago

Gene Therapy Pipeline Update: Orchard Therapeutics.. | Blog

Gene Therapy Pipeline Update: Orchard Therapeutics.. | Blog

Submitted 50 day(s) ago

Cell Therapy Market Update: MaxCyte Advances Phase | Blog

Cell Therapy Market Update: MaxCyte Advances Phase | Blog

Submitted 53 day(s) ago

Genome Editing Market Update: Intellia Therapeutics Presents.. | Blog

Genome Editing Market Update: Intellia Therapeutics Presents.. | Blog

Submitted 53 day(s) ago

Gene Therapy Pipeline Update: Adverum Biotechnologies Doses | Blog

Gene Therapy Pipeline Update: Adverum Biotechnologies Doses | Blog

Submitted 53 day(s) ago

Gene Therapy Pipeline Update: AVROBIO Receives Orphan-Drug.. | Blog

Gene Therapy Pipeline Update: AVROBIO Receives Orphan-Drug.. | Blog

Submitted 53 day(s) ago

Cell Therapy Manufacturing Update: United Therapeutics.. | Blog

Cell Therapy Manufacturing Update: United Therapeutics.. | Blog

Submitted 53 day(s) ago

Gene Therapy Funding Update: With a Promise of $100 Million.. | Blog

Gene Therapy Funding Update: With a Promise of $100 Million.. | Blog

Submitted 53 day(s) ago

Cell and Gene Therapy Technology Update: ReNeuron.. | Blog

Cell and Gene Therapy Technology Update: ReNeuron.. | Blog

Submitted 53 day(s) ago

Gene Therapy Pipeline Update: AGTC Presents Promising Data | Blog

Gene Therapy Pipeline Update: AGTC Presents Promising Data | Blog

Submitted 53 day(s) ago

Gene Therapy Pipeline Update: Rocket Pharmaceuticals.. | Blog

Gene Therapy Pipeline Update: Rocket Pharmaceuticals.. | Blog

Submitted 53 day(s) ago

Gene Therapy Pipeline Update: Homology Medicines Presents Data. | Blog

Gene Therapy Pipeline Update: Homology Medicines Presents Data. | Blog

Submitted 53 day(s) ago

Cell Therapy Manufacturing Update: Merck Becomes the First to. | Blog

Cell Therapy Manufacturing Update: Merck Becomes the First to. | Blog

Submitted 55 day(s) ago

Plasmid DNA Manufacturing Market Update: Cytovance®Introduces. | Blog

Plasmid DNA Manufacturing Market Update: Cytovance®Introduces. | Blog

Submitted 55 day(s) ago

Gene Therapy Funding Update: Exegenesis Bio raises.. | Blog

Gene Therapy Funding Update: Exegenesis Bio raises.. | Blog

Submitted 55 day(s) ago

Gene Therapy Market Update: Researchers Deliver a Cure for Epidermolysis Bullosa (EB) | Blog Gene Therapy

Gene Therapy Market Update: Researchers Deliver a Cure for Epidermolysis Bullosa (EB) | Blog Gene Therapy

Submitted 55 day(s) ago

Gene Therapy Market: A Strong Pipeline with $12 Billion Opportunity. | Blog

Gene Therapy Market: A Strong Pipeline with $12 Billion Opportunity. | Blog

Submitted 55 day(s) ago

Technological Evolution of ADC Conjugation Platforms | Blog | Blog

Technological Evolution of ADC Conjugation Platforms | Blog | Blog

Submitted 55 day(s) ago

Gene Therapy Market: Big Pharma Bets Big | Blog Gene Therapy

Gene Therapy Market: Big Pharma Bets Big | Blog Gene Therapy

Submitted 55 day(s) ago

ADC Therapeutics Market: 6th World ADC Awards Unfold... | Blog

ADC Therapeutics Market: 6th World ADC Awards Unfold... | Blog

Submitted 55 day(s) ago

10 Key Facts About Antibody Drug Conjugates Market | Blog Antibody Drug

10 Key Facts About Antibody Drug Conjugates Market | Blog Antibody Drug

Submitted 55 day(s) ago

Drug Adherence Enhancement: Novel Approaches to Drive Future | Blog

Drug Adherence Enhancement: Novel Approaches to Drive Future | Blog

Submitted 60 day(s) ago

Genomic Data Management: Opportunities for Blockchain Platform | Blog

Genomic Data Management: Opportunities for Blockchain Platform | Blog

Submitted 60 day(s) ago

Written articles

The ‘Contract Regulatory Affairs Management Market for Medical Devices, 2019-2030’ report features a detailed study on the current landscape of contract service providers focused on regulatory affairs management for medical devices.

The ‘Contract Regulatory Affairs Management Market for Medical Devices, 2019-2030’ report features a detailed study on the current landscape of contract service providers focused on regulatory affairs management for medical devices.

Submitted 7 hour(s) ago

Over 400 companies claim to possess the required expertise to offer regulatory affairs management-related services to medical device-focused business entities, claims Roots Analysis

Over 400 companies claim to possess the required expertise to offer regulatory affairs management-related services to medical device-focused business entities, claims Roots Analysis

Submitted 7 hour(s) ago

The contract regulatory affairs-management services market for medical devices is estimated to be worth USD 820 million by 2030, growing at a CAGR of 6.9%,

The contract regulatory affairs-management services market for medical devices is estimated to be worth USD 820 million by 2030, growing at a CAGR of 6.9%,

Submitted 7 hour(s) ago

The contract regulatory affairs-management services market for medical devices is estimated to be worth USD 820 million by 2030, growing at a CAGR of 6.9%, claims Roots Analysis

The contract regulatory affairs-management services market for medical devices is estimated to be worth USD 820 million by 2030, growing at a CAGR of 6.9%, claims Roots Analysis

Submitted 7 hour(s) ago

Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030” report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies

Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030” report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies

Submitted 7 hour(s) ago

Over 60 companies across the globe claim to manufacture drug products / drug substances using the continuous manufacturing technique, either for in-house requirements or for contract service engagements, claims Roots Analysis

Over 60 companies across the globe claim to manufacture drug products / drug substances using the continuous manufacturing technique, either for in-house requirements or for contract service engagements, claims Roots Analysis

Submitted 7 hour(s) ago

The continuous manufacturing market is projected to grow at an annualized rate of over 15%, till 2030

The continuous manufacturing market is projected to grow at an annualized rate of over 15%, till 2030

Submitted 7 hour(s) ago

The continuous manufacturing market is estimated to be worth around USD 2 billion in 2030, predicts Roots Analysis

The continuous manufacturing market is estimated to be worth around USD 2 billion in 2030, predicts Roots Analysis

Submitted 7 hour(s) ago

The “China Pharmaceutical Contract Manufacturing Services Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the pharmaceutical contract manufacturing market in China.

The “China Pharmaceutical Contract Manufacturing Services Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the pharmaceutical contract manufacturing market in China.

Submitted 1 day(s) ago

Presently, over 100 CMOs across the globe claim to have manufacturing facilities in China, offering services for pharmaceutical API, intermediates and FDF manufacturing, claims Roots Analysis

Presently, over 100 CMOs across the globe claim to have manufacturing facilities in China, offering services for pharmaceutical API, intermediates and FDF manufacturing, claims Roots Analysis

Submitted 1 day(s) ago

The contract manufacturing market for Pharmaceuticals in China is projected to grow at an annualized rate of ~8.9%, till 2030

The contract manufacturing market for Pharmaceuticals in China is projected to grow at an annualized rate of ~8.9%, till 2030

Submitted 1 day(s) ago

The contract manufacturing market for Pharmaceuticals in China is estimated to be worth USD 13 billion in 2030, predicts Roots Analysis

The contract manufacturing market for Pharmaceuticals in China is estimated to be worth USD 13 billion in 2030, predicts Roots Analysis

Submitted 1 day(s) ago

The “China Biopharmaceutical Contract Manufacturing Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of biopharmaceuticals in China.

The “China Biopharmaceutical Contract Manufacturing Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of biopharmaceuticals in China.

Submitted 1 day(s) ago

Over 35 CMOs / CDMOs in China claim to offer a variety of services related to development and manufacturing of a wide range of biotherapeutic products, claims Roots Analysis

Over 35 CMOs / CDMOs in China claim to offer a variety of services related to development and manufacturing of a wide range of biotherapeutic products, claims Roots Analysis

Submitted 1 day(s) ago

The Chines biopharmaceutical contract manufacturing market is projected to grow at an annualized rate of ~13%, till 2030

The Chines biopharmaceutical contract manufacturing market is projected to grow at an annualized rate of ~13%, till 2030

Submitted 1 day(s) ago

The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis

The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis

Submitted 1 day(s) ago

   The “Cell Therapy Manufacturing Market (3rd Edition), 2019-2030” features an extensive study of the current market landscape and future opportunities associated with manufacturing of cell therapies.

The “Cell Therapy Manufacturing Market (3rd Edition), 2019-2030” features an extensive study of the current market landscape and future opportunities associated with manufacturing of cell therapies.

Submitted 4 day(s) ago

More than 100 industry players and over 60 non-industry players currently claim to manufacture different types of cell therapies, either for in-house requirements or on contract basis

More than 100 industry players and over 60 non-industry players currently claim to manufacture different types of cell therapies, either for in-house requirements or on contract basis

Submitted 4 day(s) ago

The cell therapy manufacturing market is projected to grow at an annualized rate of >16.5%, till 2030

The cell therapy manufacturing market is projected to grow at an annualized rate of >16.5%, till 2030

Submitted 4 day(s) ago

The cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030, predicts Roots Analysis

The cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030, predicts Roots Analysis

Submitted 4 day(s) ago

Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030, claims Roots Analysis

Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030, claims Roots Analysis

Submitted 4 day(s) ago

 Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic entities within biocompatible matrices / carriers. Such products offer a myriad of advantages, an

Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic entities within biocompatible matrices / carriers. Such products offer a myriad of advantages, an

Submitted 4 day(s) ago

More than 45 encapsulated cell therapies and encapsulation technologies are being evaluated across different phases of development by stakeholders across the globe, claims Roots Analysis

More than 45 encapsulated cell therapies and encapsulation technologies are being evaluated across different phases of development by stakeholders across the globe, claims Roots Analysis

Submitted 4 day(s) ago

Given the increasing number of licensing deals and the expected approval of multiple mid-late stage candidates, the encapsulated cell therapies and encapsulation technologies market is anticipated to evolve at a rapid pace over the next decade, predicts R

Given the increasing number of licensing deals and the expected approval of multiple mid-late stage candidates, the encapsulated cell therapies and encapsulation technologies market is anticipated to evolve at a rapid pace over the next decade, predicts R

Submitted 4 day(s) ago

Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030” report features an extensive study of the current landscape and future outlook of the immuno-oncology biomarkers testing market (focusing particularly on TMB, MSI and TILs (CD3

Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030” report features an extensive study of the current landscape and future outlook of the immuno-oncology biomarkers testing market (focusing particularly on TMB, MSI and TILs (CD3

Submitted 6 day(s) ago

Presently, close to 50 companies are offering a variety of analytical testing solutions for the assessment of novel cancer biomarkers; majority of these tests are intended to facilitate important therapy-related decisions, claims Roots Analysis

Presently, close to 50 companies are offering a variety of analytical testing solutions for the assessment of novel cancer biomarkers; majority of these tests are intended to facilitate important therapy-related decisions, claims Roots Analysis

Submitted 6 day(s) ago

Cancer biomarkers market for TMB, MSI / MMR and TILs is projected to grow at an annualized rate of ~18%, till 2030

Cancer biomarkers market for TMB, MSI / MMR and TILs is projected to grow at an annualized rate of ~18%, till 2030

Submitted 6 day(s) ago

Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis

Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis

Submitted 6 day(s) ago

The “Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade.

The “Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade.

Submitted 6 day(s) ago

 With two approved drugs and close to 300 clinical / preclinical product candidates, the bispecific antibody therapeutics pipeline has evolved significantly over the past few years, claims Roots Analysis

With two approved drugs and close to 300 clinical / preclinical product candidates, the bispecific antibody therapeutics pipeline has evolved significantly over the past few years, claims Roots Analysis

Submitted 6 day(s) ago

The bispecific antibody therapeutics market is projected to grow at an annualized rate of ~16%, in the span of 2019 to 2030

The bispecific antibody therapeutics market is projected to grow at an annualized rate of ~16%, in the span of 2019 to 2030

Submitted 6 day(s) ago

The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis

The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis

Submitted 6 day(s) ago

Blood-Brain Barrier (BBB) Market, 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics (2nd Edition) (based on Receptor Mediated Transcytosis, Trojan Horse, and Nanoparticle based Approaches)’ report features an extensive s

Blood-Brain Barrier (BBB) Market, 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics (2nd Edition) (based on Receptor Mediated Transcytosis, Trojan Horse, and Nanoparticle based Approaches)’ report features an extensive s

Submitted 7 day(s) ago

More than 110 drugs, capable of penetrating this elusive barrier are currently being evaluated for the treatment of CNS disorders; there are nearly 35 technology platforms for the development of BBB penetrant drugs, claims Roots Analysis

More than 110 drugs, capable of penetrating this elusive barrier are currently being evaluated for the treatment of CNS disorders; there are nearly 35 technology platforms for the development of BBB penetrant drugs, claims Roots Analysis

Submitted 7 day(s) ago

The BBB penetrating drugs market is projected to grow at an annualized rate of ~154%, till 2030

The BBB penetrating drugs market is projected to grow at an annualized rate of ~154%, till 2030

Submitted 7 day(s) ago

The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030, predicts Roots Analysis

The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030, predicts Roots Analysis

Submitted 7 day(s) ago

Biopharmaceutical Contract Manufacturing Market (3rd edition), 2019 – 2030” report features an extensive study on the contract service providers within the biopharmaceutical industry.

Biopharmaceutical Contract Manufacturing Market (3rd edition), 2019 – 2030” report features an extensive study on the contract service providers within the biopharmaceutical industry.

Submitted 7 day(s) ago

Over 235 companies worldwide claim to offer contract manufacturing services for various types of biopharmaceutical drug / therapy products

Over 235 companies worldwide claim to offer contract manufacturing services for various types of biopharmaceutical drug / therapy products

Submitted 7 day(s) ago

The biopharmaceutical contract manufacturing market is projected to grow at an annualized rate of ~8%, till 2030

The biopharmaceutical contract manufacturing market is projected to grow at an annualized rate of ~8%, till 2030

Submitted 7 day(s) ago

The biopharmaceutical contract manufacturing market is estimated to be worth USD 13.9 billion in 2030, predicts Roots Analysis

The biopharmaceutical contract manufacturing market is estimated to be worth USD 13.9 billion in 2030, predicts Roots Analysis

Submitted 7 day(s) ago

The ‘Biologics Fill / Finish Service Providers, 2019-2030’ report features an extensive study on the contract service providers offering drug product manufacturing services within the biopharmaceutical industry. The study features in-depth analysis, highl

The ‘Biologics Fill / Finish Service Providers, 2019-2030’ report features an extensive study on the contract service providers offering drug product manufacturing services within the biopharmaceutical industry. The study features in-depth analysis, highl

Submitted 8 day(s) ago

Over 115 companies located in various regions across the globe claim to provide contract fill / finish services for various types of biopharmaceutical drug / therapy products, claims Roots Analysis

Over 115 companies located in various regions across the globe claim to provide contract fill / finish services for various types of biopharmaceutical drug / therapy products, claims Roots Analysis

Submitted 8 day(s) ago

The contract fill / finish services market for biologics market is projected to grow at an annualized rate of ~10%, till 2030

The contract fill / finish services market for biologics market is projected to grow at an annualized rate of ~10%, till 2030

Submitted 8 day(s) ago

The contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030, predicts Roots Analysis

The contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030, predicts Roots Analysis

Submitted 8 day(s) ago

The ‘AR / VR based Healthcare Digital Marketing Service Providers, 2020-2030’ report features an extensive study of the current market landscape and future opportunities associated with the AR / VR based digital marketing industry in the healthcare domain

The ‘AR / VR based Healthcare Digital Marketing Service Providers, 2020-2030’ report features an extensive study of the current market landscape and future opportunities associated with the AR / VR based digital marketing industry in the healthcare domain

Submitted 8 day(s) ago

Presently, more than 120 companies claim to offer AR / VR and affiliated digital marketing services to the global healthcare industry, claims Roots Analysis

Presently, more than 120 companies claim to offer AR / VR and affiliated digital marketing services to the global healthcare industry, claims Roots Analysis

Submitted 8 day(s) ago

The AR / VR based digital marketing service providers in healthcare sector market is projected to grow at an annualized rate of ~30%, till 2030

The AR / VR based digital marketing service providers in healthcare sector market is projected to grow at an annualized rate of ~30%, till 2030

Submitted 8 day(s) ago

The market opportunity for AR / VR based healthcare digital marketing service providers is likely to grow at a CAGR of 26%, till 2030

The market opportunity for AR / VR based healthcare digital marketing service providers is likely to grow at a CAGR of 26%, till 2030

Submitted 8 day(s) ago

The opportunity for AR / VR based digital marketing service providers in healthcare sector is projected to be worth USD 3 billion by 2030 at significant CAGR of 26% claims, Roots Analysis

The opportunity for AR / VR based digital marketing service providers in healthcare sector is projected to be worth USD 3 billion by 2030 at significant CAGR of 26% claims, Roots Analysis

Submitted 8 day(s) ago

The ‘Antibody Drug Conjugates Market (5th Edition), 2019-2030’ report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade.

The ‘Antibody Drug Conjugates Market (5th Edition), 2019-2030’ report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade.

Submitted 11 day(s) ago

Presently, over 240 ADC therapy candidates are being evaluated in clinical / preclinical stages for treating a variety of solid tumors / hematologic cancers, claims Roots Analysis

Presently, over 240 ADC therapy candidates are being evaluated in clinical / preclinical stages for treating a variety of solid tumors / hematologic cancers, claims Roots Analysis

Submitted 11 day(s) ago

The antibody drug conjugates market is projected to grow at an annualized rate of over 20%, till 2030

The antibody drug conjugates market is projected to grow at an annualized rate of over 20%, till 2030

Submitted 11 day(s) ago

The antibody drug conjugates market is estimated to be worth more than 15 billion in 2030, predicts Roots Analysis

The antibody drug conjugates market is estimated to be worth more than 15 billion in 2030, predicts Roots Analysis

Submitted 11 day(s) ago

The “Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely future evolution in this industry over the next ten years

The “Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely future evolution in this industry over the next ten years

Submitted 11 day(s) ago

Over 80 firms are involved in providing antibody drug discovery-related services; whereas close to 125 players are offering antibody discovery platforms

Over 80 firms are involved in providing antibody drug discovery-related services; whereas close to 125 players are offering antibody discovery platforms

Submitted 11 day(s) ago

The antibody discovery services and platforms market is projected to grow at an annualized rate of ~10%, till 2030

The antibody discovery services and platforms market is projected to grow at an annualized rate of ~10%, till 2030

Submitted 11 day(s) ago

 The antibody discovery services market is estimated to be worth around USD 6.5 billion by 2030 instead the antibody discovery platforms market is anticipated to be worth close to USD 6 billion by 2030, predicts Roots Analysis

The antibody discovery services market is estimated to be worth around USD 6.5 billion by 2030 instead the antibody discovery platforms market is anticipated to be worth close to USD 6 billion by 2030, predicts Roots Analysis

Submitted 11 day(s) ago

Growing at an annualized rate of over 9%, the antibody discovery services market is projected to be worth USD 6.5 billion by 2030; the antibody discovery platforms market is estimated to be worth close to USD 6 billion by 2030: Roots Analysis

Growing at an annualized rate of over 9%, the antibody discovery services market is projected to be worth USD 6.5 billion by 2030; the antibody discovery platforms market is estimated to be worth close to USD 6 billion by 2030: Roots Analysis

Submitted 11 day(s) ago

Targeted Protein Degradation Market, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics and affiliated technologies, over the next decade.

Targeted Protein Degradation Market, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics and affiliated technologies, over the next decade.

Submitted 12 day(s) ago

More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications; in addition, there are over 25 technology platforms available for use in therapy development efforts

More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications; in addition, there are over 25 technology platforms available for use in therapy development efforts

Submitted 12 day(s) ago

The targeted protein degradation market is projected to grow at an annualized rate of more than 30% till 2030

The targeted protein degradation market is projected to grow at an annualized rate of more than 30% till 2030

Submitted 12 day(s) ago

Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair (including PARP Inhibitors) and Other Novel Cellular Pathways” report features an extensive study of the current market landscape and the future potential of the synthetic

Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair (including PARP Inhibitors) and Other Novel Cellular Pathways” report features an extensive study of the current market landscape and the future potential of the synthetic

Submitted 12 day(s) ago

About 75 drug candidates based on synlet gene pairs are being evaluated for the treatment of various types of cancers; presently, there are over 20 screening platforms enabling therapy development efforts

About 75 drug candidates based on synlet gene pairs are being evaluated for the treatment of various types of cancers; presently, there are over 20 screening platforms enabling therapy development efforts

Submitted 12 day(s) ago

The synthetic lethality-based drugs and targets market is projected to grow at an annualized rate of ~18%, till 2030

The synthetic lethality-based drugs and targets market is projected to grow at an annualized rate of ~18%, till 2030

Submitted 12 day(s) ago

The synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 2030, predicts Roots Analysis

The synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 2030, predicts Roots Analysis

Submitted 12 day(s) ago

More than 100 subcutaneous biologics have been approved and over 350 such drug candidates are being evaluated in the clinical stages of development, for the treatment of a wide variety of disease indications, claims Roots Analysis

More than 100 subcutaneous biologics have been approved and over 350 such drug candidates are being evaluated in the clinical stages of development, for the treatment of a wide variety of disease indications, claims Roots Analysis

Submitted 13 day(s) ago

The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030

The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030

Submitted 13 day(s) ago

The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030, predicts Roots Analysis

The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030, predicts Roots Analysis

Submitted 13 day(s) ago

Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 (based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal, Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow, Cardiosphere, Chond

Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 (based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal, Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow, Cardiosphere, Chond

Submitted 13 day(s) ago

More than 120 industry players are engaged in evaluating the potential of over 280 stem cell therapy products for the treatment of a variety of disease indications

More than 120 industry players are engaged in evaluating the potential of over 280 stem cell therapy products for the treatment of a variety of disease indications

Submitted 13 day(s) ago

With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis

With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis

Submitted 13 day(s) ago

With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis

With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis

Submitted 13 day(s) ago

The “RNAi Therapeutics Market (2nd Edition), 2019 - 2030: Focus on siRNA, miRNA, shRNA and DNA” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade

The “RNAi Therapeutics Market (2nd Edition), 2019 - 2030: Focus on siRNA, miRNA, shRNA and DNA” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade

Submitted 14 day(s) ago

  Presently, there are two approved drug and over 150 product candidates, which are being evaluated for the treatment of a variety of disease indications, based on the RNAi principle, claims Roots Analysis

  Presently, there are two approved drug and over 150 product candidates, which are being evaluated for the treatment of a variety of disease indications, based on the RNAi principle, claims Roots Analysis

Submitted 14 day(s) ago

RNAi Therapeutics Market is projected to grow at an annualized rate of ~45%, till 2030

RNAi Therapeutics Market is projected to grow at an annualized rate of ~45%, till 2030

Submitted 14 day(s) ago

RNAi Therapeutics Market is estimated to be worth USD 9.2 billion in 2030, predicts Roots Analysis

RNAi Therapeutics Market is estimated to be worth USD 9.2 billion in 2030, predicts Roots Analysis

Submitted 14 day(s) ago

The RNAi therapeutics market is anticipated to grow at an annualized rate of more than 45%, till 2030, claims Roots Analysis

The RNAi therapeutics market is anticipated to grow at an annualized rate of more than 45%, till 2030, claims Roots Analysis

Submitted 14 day(s) ago

Psychedelic substances have been demonstrated to interact with a variety of neurotransmitter pathways, including those involving serotonin, acetylcholine, norepinephrine, and dopamine. Currently, several stakeholders in the pharmaceutical industry are act

Psychedelic substances have been demonstrated to interact with a variety of neurotransmitter pathways, including those involving serotonin, acetylcholine, norepinephrine, and dopamine. Currently, several stakeholders in the pharmaceutical industry are act

Submitted 14 day(s) ago

Nearly 70 players from across the world presently claim to be engaged in the development and evaluation of therapeutic candidates based on a number of psychedelic compounds, such as ketamine and psilocybin, claims Roots Analysis

Nearly 70 players from across the world presently claim to be engaged in the development and evaluation of therapeutic candidates based on a number of psychedelic compounds, such as ketamine and psilocybin, claims Roots Analysis

Submitted 14 day(s) ago

A growing body of evidence suggests that using psychedelics, such as psilocybin and LSD, in combination with psychotherapy, can treat the symptoms of several mental health conditions, including depression and substance use disorders  Roots Analysis has an

A growing body of evidence suggests that using psychedelics, such as psilocybin and LSD, in combination with psychotherapy, can treat the symptoms of several mental health conditions, including depression and substance use disorders Roots Analysis has an

Submitted 14 day(s) ago

Global Psychedelic therapeutics market is estimated to be worth over USD 6.5 billion in 2030, predicts Roots Analysis

Global Psychedelic therapeutics market is estimated to be worth over USD 6.5 billion in 2030, predicts Roots Analysis

Submitted 14 day(s) ago

The ‘Prefilled Syringes Market (5th edition), 2019-2030’ report features an extensive study of the current market landscape of prefilled syringes and the likely future opportunities associated with such devices, over the next 10-12 years.

The ‘Prefilled Syringes Market (5th edition), 2019-2030’ report features an extensive study of the current market landscape of prefilled syringes and the likely future opportunities associated with such devices, over the next 10-12 years.

Submitted 19 day(s) ago

Presently, around 80 types of prefilled syringes are available in the market, and several companies claim to be engaged in the manufacturing of both glass and plastic variants of such versatile drug delivery solutions, claims Roots Analysis

Presently, around 80 types of prefilled syringes are available in the market, and several companies claim to be engaged in the manufacturing of both glass and plastic variants of such versatile drug delivery solutions, claims Roots Analysis

Submitted 19 day(s) ago

The prefilled syringes market is projected to grow at an annualized rate of ~5%, till 2030

The prefilled syringes market is projected to grow at an annualized rate of ~5%, till 2030

Submitted 19 day(s) ago

The prefilled syringes market is estimated to be worth over USD 2.5 billion in 2030, predicts Roots Analysis

The prefilled syringes market is estimated to be worth over USD 2.5 billion in 2030, predicts Roots Analysis

Submitted 19 day(s) ago

The “Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020-2030” report features an extensive study on the current market landscape and future of companies offering services for peptides and macrocycle drug discovery operations.

The “Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020-2030” report features an extensive study on the current market landscape and future of companies offering services for peptides and macrocycle drug discovery operations.

Submitted 19 day(s) ago

More than 35 industry players claim to offer services for the identification, characterization and development of peptides and macrocycle-based pharmacological lead candidates, claims Roots Analysis

More than 35 industry players claim to offer services for the identification, characterization and development of peptides and macrocycle-based pharmacological lead candidates, claims Roots Analysis

Submitted 19 day(s) ago

The next generation immune checkpoint inhibitors and stimulators market is projected to grow at an annualized rate of ~10.5%, till 2030

The next generation immune checkpoint inhibitors and stimulators market is projected to grow at an annualized rate of ~10.5%, till 2030

Submitted 19 day(s) ago

The peptides and macrocycle drug discovery services market is estimated to be worth USD 1.5 billion in 2030, predicts Roots Analysis

The peptides and macrocycle drug discovery services market is estimated to be worth USD 1.5 billion in 2030, predicts Roots Analysis

Submitted 19 day(s) ago

Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of therapeutic peptides.

Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of therapeutic peptides.

Submitted 20 day(s) ago

Currently, around 50 companies claim to manufacture peptide-based therapeutics; such players also claim to be capable of providing a variety of additional services to their clients

Currently, around 50 companies claim to manufacture peptide-based therapeutics; such players also claim to be capable of providing a variety of additional services to their clients

Submitted 20 day(s) ago

Peptide Therapeutics: Contract API manufacturing market is projected to grow at an annualized rate of ~11.2%, till 2030

Peptide Therapeutics: Contract API manufacturing market is projected to grow at an annualized rate of ~11.2%, till 2030

Submitted 20 day(s) ago

Peptide Therapeutics: Contract API manufacturing market is estimated to be worth USD 3.2 billion in 2030, predicts Roots Analysis

Peptide Therapeutics: Contract API manufacturing market is estimated to be worth USD 3.2 billion in 2030, predicts Roots Analysis

Submitted 20 day(s) ago

Patient Recruitment and Retention Services, 2019-2030’ report offers a comprehensive study of the current scenario and future potential of the players providing patient enrollment and retention services. The study features an in-depth analysis, highlighti

Patient Recruitment and Retention Services, 2019-2030’ report offers a comprehensive study of the current scenario and future potential of the players providing patient enrollment and retention services. The study features an in-depth analysis, highlighti

Submitted 20 day(s) ago

Presently, close to 140 companies claim to be actively engaged in offering patient recruitment / retention services to the pharmaceutical and medical devices industries, employing a variety of outreach methods and solutions, claims Roots Analysis

Presently, close to 140 companies claim to be actively engaged in offering patient recruitment / retention services to the pharmaceutical and medical devices industries, employing a variety of outreach methods and solutions, claims Roots Analysis

Submitted 20 day(s) ago

The patient recruitment and retention services market is projected to grow at an annualized rate of ~5%, till 2030

The patient recruitment and retention services market is projected to grow at an annualized rate of ~5%, till 2030

Submitted 20 day(s) ago

The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030, predicts Roots Analysis

The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030, predicts Roots Analysis

Submitted 20 day(s) ago

Ophthalmic Drugs Contract Manufacturing Market, 2020-2030” report features an extensive study of the contract services market for ophthalmic APIs and drug FDFs (including ophthalmic drops, emulsions, gels, injections, lotions, ointments, suspensions, and

Ophthalmic Drugs Contract Manufacturing Market, 2020-2030” report features an extensive study of the contract services market for ophthalmic APIs and drug FDFs (including ophthalmic drops, emulsions, gels, injections, lotions, ointments, suspensions, and

Submitted 21 day(s) ago

More than 240 companies across the globe claim to have the required capabilities to offer variety of services on a contract basis, working at different scales of operation, for a wide range of ophthalmic APIs and drug FDFs, claims Roots Analysis

More than 240 companies across the globe claim to have the required capabilities to offer variety of services on a contract basis, working at different scales of operation, for a wide range of ophthalmic APIs and drug FDFs, claims Roots Analysis

Submitted 21 day(s) ago

The ophthalmic drugs contract manufacturing market is projected to grow at an annualized rate of ~8%, till 2030

The ophthalmic drugs contract manufacturing market is projected to grow at an annualized rate of ~8%, till 2030

Submitted 21 day(s) ago

Created businesses